Share-based Payment Arrangement, Expense in USD of Galera Therapeutics, Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Galera Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2018 to Q3 2025.
  • Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $91K, a 83.5% decline year-over-year.
  • Galera Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $714K, a 78.6% decline year-over-year.
  • Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $2.55M, a 54.2% decline from 2023.
  • Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.56M, a 22.4% decline from 2022.
  • Galera Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.16M, a 0.93% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Galera Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $714K $91K -$460K -83.5% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $1.17M $90K -$633K -87.6% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $1.81M $137K -$738K -84.3% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $2.55M $396K -$791K -66.6% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 $3.34M $551K -$839K -60.4% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $4.18M $723K -$802K -52.6% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 $4.98M $875K -$583K -40% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $5.56M $1.19M -$549K -31.6% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $6.11M $1.39M -$360K -20.6% 01 Jul 2023 30 Sep 2023 10-Q 13 Dec 2024
Q2 2023 $6.47M $1.53M -$305K -16.7% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $6.77M $1.46M -$390K -21.1% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $7.16M $1.74M -$223K -11.4% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $7.39M $1.75M -$120K -6.42% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $7.51M $1.83M +$219K +13.6% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $7.29M $1.85M +$57K +3.18% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $7.23M $1.96M +$591K +43.2% 01 Oct 2021 31 Dec 2021 10-K 08 Mar 2023
Q3 2021 $6.64M $1.87M +$365K +24.3% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $6.28M $1.61M +$158K +10.9% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $6.12M $1.79M +$581K +48% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $5.54M $1.37M +$562K +69.7% 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $4.97M $1.51M +$985K +189% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $3.99M $1.45M +$888K +157% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021
Q1 2020 $3.1M $1.21M +$711K +142% 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 $2.39M $806K 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 $520K +$300K +136% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $565K 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $499K 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q3 2018 $220K 01 Jul 2018 30 Sep 2018 10-Q 10 Dec 2019

Galera Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.55M -$3.02M -54.2% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $5.56M -$1.6M -22.4% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $7.16M -$67K -0.93% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $7.23M +$1.7M +30.6% 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2023
2020 $5.54M +$3.15M +132% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022
2019 $2.39M +$1.53M +176% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021
2018 $865K 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.